Don't have a Account?
It's fast, free and easy to sign in with Facebook, Google, or Yahoo. Be connected on your terms - we won't share anything without your permission
| Connect with us
Japan, which has the lowest infant mortality rate and highest adult life expectancy in the world, is fast turning into an aging society. A survey by the country's...
The pharmaceutical market in India is highly competitive because of affordable medicine with low-priced, locally-produced generics. India accounts for less than...
Sigma-Aldrich, a leading life sciences and high technology company headquartered in the US, recently opened new facilities in Wuxi, China, and Bangalore, India....
South Korea has high growth potential in the life sciences industry with its strong governmental support, highly educated personnel, growing infrastructure, and...
Life Technologies, a US-based biotechnology company with customers in more than 160 countries, introduced a new benchtop Ion Proton Sequencer in India designed to...
The Asia Pacific healthcare market is estimated to capture 34.6 percent of the global healthcare market by 2015. Frost & Sullivan says that by 2020, healthcare expenditure...
Continuous drug price cuts will further squeeze margins for both multinational and domestic pharma. "The National Reform and Development Commission (NRDC), China's...
For the CRO industry, the biggest challenge will be to develop a credible mid-sized offering to the industry. Currently, this does not exist. (Read about all 10...
Finding the perfect partners in the supply chain, marketing channels and co-development collaborations to ensure maximum speed and growth of product development,...
Fluctuation in currency value has resulted in many companies showing a negative growth. Even inflation has a direct impact on the cost of living leading to attrition...
The regulatory environment for life sciences companies is known for its challenging nature. The framework is confusing and at times overshoots the understandable...
Government policies are among the major challenges before companies operating in the life sciences sector in the Asia Pacific region. For larger multinationals,...
Lack of appropriate funding for early- to mid-stage innovation companies, limited local capital, local grants for small biotechnology firms related to the percentage...
The Asia Pacific region, barring the developed nations of Australia and Singapore, needs "critical mass" where interdependent biotechnology firms can exist and support...
Lack of trained and skilled workforce, identifying a market-savvy work force and retaining the right people on key positions are problems in certain regions, especially...
Do countries like Taiwan and Korea need more biotech parks?
Subscribe to BioSpectrum Asia
Print Edition: Connect with email@example.com
Digital Edition: Click here to Subscribe for BioSpectrum Asia Digital Edition
BioSpectrum Asia Newsletters
Sign up for the daily news from Asia bioscience industry
Copyright © 2016 MM ACTIV. All rights reserved.
Reproduction in whole or in part in any form or medium without written permission is prohibited.
Send this article by email